
Medico Remedies Share: Bull Case vs Bear Case for 2026
Updated: 16 Sept 2026 • 12:29 pm
Posted by:

Medico Remedies Key Stats (16 Sep 2026)
| Sector | Pharmaceutical Formulations Manufacturing |
| Current Market Price | Rs 35.60 |
| 52 Week High / Low | Rs 56.88 / Rs 30.22 |
| Market Cap (Rs Cr) | 298 |
| P/E Ratio (Industry P/E) | 21.61 (51.01) |
| Return on Equity | 17.38% |
| Debt to Equity | 0.25 |
| EPS (TTM) | Rs 1.66 |
| Dividend Yield | 0.00% |
| Book Value | Rs 9.10 |
| 14 Day RSI | 29.11 |
Quick Answer
The Medico Remedies bull case rests on extraordinarily deep discount to industry valuation, while the bear case points to trading at a very significant premium to book value. At Rs 35.60, the stock sits between its 52 week low of Rs 30.22 and high of Rs 56.88, and both sides of the argument deserve a look before deciding. This article lays out the fundamentals and technical signals so you can weigh the Medico Remedies bull case against the risks yourself.
Medico Remedies operates in the pharmaceutical formulations manufacturing space, and its shares currently trade at Rs 35.60, placing the stock within a 52 week range of Rs 30.22 to Rs 56.88. For anyone building or reviewing a position, the Medico Remedies bull case and the bear case both come down to the same underlying numbers read in different lights, and this piece walks through both sides using the company's latest valuation, profitability, and technical readings.
Rather than pushing you toward one conclusion, this Medico Remedies bull case analysis sets out what the bulls see in Medico Remedies shares and what the bears are watching, so you can match the picture against your own risk appetite and investment horizon. Understanding the Medico Remedies bull case thoroughly, alongside its counterpart, is essential before making any investment decision.
Click Here – Get Free Investment Predictions
Medico Remedies Bull Case: Why Medico Remedies Could Move Higher
Building the Medico Remedies bull case means looking closely at the metrics investors watch most: valuation, profitability, leverage, and price momentum. Here is what supports the Medico Remedies bull case for Medico Remedies shares right now.
Extraordinarily Deep Discount to Industry Valuation: Medico Remedies trades at just 21.61 times earnings against a pharmaceutical industry average of 51.01, one of the widest valuation gaps in this entire batch.
Exceptional Return on Equity: A return on equity of 17.38 percent is outstanding, reflecting highly efficient capital use in the pharmaceutical formulations business.
Manageable Leverage: A debt to equity ratio of 0.25 keeps the balance sheet reasonably conservative.
Deeply Oversold Setup: The 14 day RSI near 29.11 places the stock in oversold territory, a zone some investors watch for a potential base building phase.
Taken together, these points form the core of the Medico Remedies bull case for Medico Remedies, though as with any thesis, they should be weighed against the risks on the other side.
Explore the Univest Stock Screener
The Bear Case: Risks Facing Medico Remedies
No Medico Remedies bull case is complete without an honest look at what could go wrong. The following factors form the bear case for Medico Remedies shares.
Trading at a Very Significant Premium to Book Value: With a book value of Rs 9.10 per share against a market price of Rs 35.60, the stock trades at a very significant premium to its accounting net worth.
No Current Dividend: A 0 percent dividend yield means the stock currently offers no income cushion for shareholders.
Extraordinarily Sharp Decline From 52 Week High: The stock trades at roughly 63 percent of its 52 week high of Rs 56.88, reflecting an extraordinarily significant de-rating over the past year.
Pharmaceutical Formulations Regulatory Risk: Pharmaceutical formulations manufacturers are exposed to regulatory inspection outcomes and pricing pressure in export markets.
Download the Univest iOS App or the Univest Android App to track this stock on the go.
Conclusion
The Medico Remedies bull case and the bear case for Medico Remedies both draw on the same set of numbers, valuation, return on equity, leverage, and price momentum, interpreted from opposite directions. At Rs 35.60, Medico Remedies shares sit in a 52 week range of Rs 30.22 to Rs 56.88, and where the stock goes from here will likely depend on which side of the Medico Remedies bull case versus bear case debate dominates investor sentiment. As with any stock, independent research and a clear view of your own risk tolerance should guide any final decision, and revisiting the Medico Remedies bull case periodically as new data emerges is a sound practice.
Disclaimer: This article is for informational purposes only and should not be construed as investment advice. Univest Research Analyst services are provided under SEBI Registration No. INH000013776. Stock prices, financial ratios, and technical indicators mentioned above are as of 16 Sep 2026 and are subject to change; please verify all data independently before making any investment decision. Past performance is not indicative of future results. Investments in securities are subject to market risk.
Frequently Asked Questions
What is the Medico Remedies bull case for the stock?
Ans. The Medico Remedies bull case for Medico Remedies centers on extraordinarily deep discount to industry valuation, among other factors covered above, though investors should weigh this alongside the risks discussed in the bear case section.
What is the bear case for Medico Remedies shares?
Ans. The primary risk highlighted in the bear case is trading at a very significant premium to book value, and investors should factor this in before making a decision.
What is the current share price of Medico Remedies?
Ans. Medico Remedies shares currently trade at Rs 35.60, within a 52 week range of Rs 30.22 to Rs 56.88.
What is the P/E ratio of Medico Remedies?
Ans. Medico Remedies trades at a P/E ratio of 21.61, compared with a broader industry average of around 51.01.
What is the return on equity for Medico Remedies?
Ans. Medico Remedies reported a return on equity of 17.38 percent.
Is Medico Remedies a debt heavy company?
Ans. Medico Remedies carries a debt to equity ratio of 0.25, which investors can compare against sector peers to judge balance sheet risk.
What is the 52 week high and low for Medico Remedies?
Ans. Medico Remedies has a 52 week high of Rs 56.88 and a 52 week low of Rs 30.22.
Should I rely only on this article before investing in Medico Remedies?
Ans. No. This Medico Remedies bull case article presents both the Medico Remedies bull case and the bear case using publicly available fundamentals and technical data as of 16 Sep 2026, but you should verify all figures independently and consider consulting a registered investment adviser before making any investment decision.
Recent Articles
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Mcleod Russel India Share: Bull Case vs Bear Case for 2026
Medi Assist Healthcare Services Share: Bull Case vs Bear Case for 2026
Meesho Share: Bull Case vs Bear Case for 2026
Megastar Foods Share: Bull Case vs Bear Case for 2026
Meghmani Organics Share: Bull Case vs Bear Case for 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





